Caitong International Asset Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,464
Closed -$2.36K 2868
2025
Q4
$2.36K Buy
1,464
+1,331
+1,001% +$2.09K ﹤0.01% 1303
2025
Q3
$223 Buy
+133
New +$215 ﹤0.01% 1656

Other funds holding MGNX

Caitong International Asset Management's MGNX Position: Q1 2026 in Review

Caitong International Asset Management sold out of MacroGenics (MGNX) in Q1 2026, closing a stake of 1,464 shares — an estimated $2.36K sold.

Caitong International Asset Management first reported a position in MGNX in Q3 2025 and held it in 2 quarters. The position peaked at $2.36K in Q4 2025. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Caitong International Asset Management reported no remaining MacroGenics position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 1,464 MacroGenics shares in Q1 2026, an estimated $2.36K.
  • Caitong International Asset Management first reported a position in MacroGenics in Q3 2025 and held it in 2 quarters.
  • Caitong International Asset Management's MacroGenics position peaked at $2.36K in Q4 2025.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.